I think all the long termers need to keep the faith and be conscious of that whilst its not a great SP at present agreed, we should acknowledge where we should be on the current status... We have never been in a more qualified situation to bring home the bacon IMO, & importantly a renewed hope for the individuals within the HT trial for a new chance at a quality life.
We need to survey where we are at now finally in HT, a low tox, qualified NHP, & with a plus 50-70% chance communicated by Management of commercialisation of our first drug, higher probabilities of partnership, & compare this to where we have been at much higher SP's +17's in a much, much lower qualifying & news stage. I thus feel the most confident that I ever have in 12+ years as a shareholder at success & beneficial outcomes for the supporters of PYC.
IMO, I am thinking 20 + mid year on news pos. flow & creeping to end of year news outcomes. I "suspect" a surprise announcement to please all for much higher; this purely based on the data, current stage, & interview comments of partnership probabilities based on data & HT stages to please us all on the ASX.
The language & excitement seen in interviews on the 4 drugs does form some of my current opinion, however the data and senior management & stakeholders % loading also adds. The additional benefits of the AI partnership for additional revenue streams is a +. I remember the days of SP 1c & running on the smell of an oily rag with a 1m grant each year to keep the wheels turning to where we see ourselves today ! WOW, look at us now.
I believe we are in for a bumper crop this year & I hope I'm not proved wrong all ! GLTAH. I'm still buying !
- Forums
- ASX - By Stock
- PYC
- PYC Chart and Technical Analysis
PYC Chart and Technical Analysis, page-10
-
- There are more pages in this discussion • 222 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PYC (ASX) to my watchlist
(20min delay)
|
|||||
Last
20.0¢ |
Change
0.010(5.26%) |
Mkt cap ! $933.2M |
Open | High | Low | Value | Volume |
19.0¢ | 20.0¢ | 18.8¢ | $963.9K | 4.978M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 2692 | 19.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
20.0¢ | 445208 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 2692 | 0.190 |
5 | 135217 | 0.185 |
10 | 456952 | 0.180 |
5 | 223750 | 0.175 |
12 | 452263 | 0.170 |
Price($) | Vol. | No. |
---|---|---|
0.200 | 445208 | 3 |
0.205 | 650000 | 5 |
0.210 | 1048799 | 10 |
0.215 | 870300 | 4 |
0.220 | 944571 | 2 |
Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
Featured News
PYC (ASX) Chart |
The Watchlist
EQN
EQUINOX RESOURCES LIMITED.
Zac Komur, MD & CEO
Zac Komur
MD & CEO
SPONSORED BY The Market Online